Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa
Background: Breast cancer is the third commonest cancer in women in Uganda. The majority of breast cancer patients in Uganda present with advanced disease. Many studies show that metastatic lesions frequently lodge in bones, lung and liver. Tumour hormone receptor status correlates with site of meta...
Main Authors: | Nabawanuka A, Galukande M, Nalwoga H, Gakwaya A |
---|---|
Format: | Article |
Language: | English |
Published: |
Surgical Society of Kenya
2018-10-01
|
Series: | The Annals of African Surgery |
Subjects: | |
Online Access: | https://www.annalsofafricansurgery.com/metastatic-breast-cancer-and-hormon |
Similar Items
-
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer
by: Xuan Ge, et al.
Published: (2022-09-01) -
Efficacy of enzalutamide in patients with metastatic hormone-sensitive and castration-refractory prostate cancer: authors’ experience
by: T. V. Ustinova, et al.
Published: (2021-12-01) -
Real-world data of HER2-low metastatic breast cancer: A population based cohort study
by: Emily I. Holthuis, et al.
Published: (2022-12-01) -
Palbociclib in the first line combination hormone therapy of HER2- negative metastatic hormone-dependent breast cancer. Clinical follow-up
by: M. A. Frolova, et al.
Published: (2018-07-01) -
Preferences for the sequencing of first-line systemic treatments in metastatic hormone receptor-positive, HER2-negative breast cancer
by: Layal Al Mahmasani, et al.
Published: (2023-10-01)